['DOSE OF FOSAPREPITANT/ APREPITANT', 'DOSE OF MIDAZOLAM', 'OBSERVED DRUG INTERACTIONS', 'FOSAPREPITANT 150 MG ON DAY 1', 'ORAL 2 MG ON DAYS 1 AND 4', 'AUC \xe2\x86\x91 1.8-FOLD ON DAY 1 AND AUC \xe2\x86\x94 ON DAY 4', 'FOSAPREPITANT 100\xc2\xa0MG ON DAY 1', 'ORAL 2\xc2\xa0MG', 'ORAL MIDAZOLAM AUC \xe2\x86\x91 1.6-FOLD', 'ORAL APREPITANT 125\xc2\xa0MG ON DAY 1 AND 80\xc2\xa0MG ON DAYS 2 TO 5', 'ORAL 2\xc2\xa0MG SD ON DAYS 1 AND 5', 'ORAL MIDAZOLAM AUC \xe2\x86\x91 2.3-FOLD ON DAY 1 AND \xe2\x86\x91 3.3-FOLD ON DAY 5', 'ORAL APREPITANT 125\xc2\xa0MG ON DAY 1 AND 80\xc2\xa0MG ON DAYS 2 AND 3', 'INTRAVENOUS 2 MG PRIOR TO 3-DAY REGIMEN OF APREPITANT AND ON DAYS 4, 8 AND 15', 'INTRAVENOUS MIDAZOLAM AUC \xe2\x86\x91 25% ON DAY 4, AUC \xe2\x86\x93 19% ON DAY 8 AND AUC \xe2\x86\x93 4% ON DAY 15', 'ORAL APREPITANT 125\xc2\xa0MG', 'INTRAVENOUS 2\xc2\xa0MG GIVEN 1 HOUR AFTER APREPITANT', 'INTRAVENOUS MIDAZOLAM AUC \xe2\x86\x91 1.5-FOLD']